These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 37894990)

  • 1. CRISPR-Cas Technology for Bioengineering Conventional and Non-Conventional Yeasts: Progress and New Challenges.
    Xia Y; Li Y; Shen W; Yang H; Chen X
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-mediated genome editing in non-conventional yeasts for biotechnological applications.
    Cai P; Gao J; Zhou Y
    Microb Cell Fact; 2019 Apr; 18(1):63. PubMed ID: 30940138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas system for yeast genome engineering: advances and applications.
    Stovicek V; Holkenbrink C; Borodina I
    FEMS Yeast Res; 2017 Aug; 17(5):. PubMed ID: 28505256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR system in the yeast Saccharomyces cerevisiae and its application in the bioproduction of useful chemicals.
    Mitsui R; Yamada R; Ogino H
    World J Microbiol Biotechnol; 2019 Jul; 35(7):111. PubMed ID: 31280424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering Kluyveromyces marxianus as a Robust Synthetic Biology Platform Host.
    Cernak P; Estrela R; Poddar S; Skerker JM; Cheng YF; Carlson AK; Chen B; Glynn VM; Furlan M; Ryan OW; Donnelly MK; Arkin AP; Taylor JW; Cate JHD
    mBio; 2018 Sep; 9(5):. PubMed ID: 30254120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing CRISPR-Cas technologies in conventional and non-conventional yeasts: Current state and future prospects.
    Raschmanová H; Weninger A; Glieder A; Kovar K; Vogl T
    Biotechnol Adv; 2018; 36(3):641-665. PubMed ID: 29331410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas12a Multiplex Genome Editing of Saccharomyces cerevisiae and the Creation of Yeast Pixel Art.
    Ciurkot K; Vonk B; Gorochowski TE; Roubos JA; Verwaal R
    J Vis Exp; 2019 May; (147):. PubMed ID: 31205318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast Still a Beast: Diverse Applications of CRISPR/Cas Editing Technology in
    Giersch RM; Finnigan GC
    Yale J Biol Med; 2017 Dec; 90(4):643-651. PubMed ID: 29259528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of CRISPR/Cas System in the Metabolic Engineering of Small Molecules.
    Singh R; Chandel S; Ghosh A; Dey D; Chakravarti R; Roy S; Ravichandiran V; Ghosh D
    Mol Biotechnol; 2021 Jun; 63(6):459-476. PubMed ID: 33774733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances and Opportunities of CRISPR/Cas Technology in Bioengineering Non-conventional Yeasts.
    Shan L; Dai Z; Wang Q
    Front Bioeng Biotechnol; 2021; 9():765396. PubMed ID: 34708030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiplex gene editing and regulation techniques based on CRISPR/Cas system].
    Fan X; Wang J; Liang L; Liu R
    Sheng Wu Gong Cheng Xue Bao; 2023 Jun; 39(6):2449-2464. PubMed ID: 37401603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR technologies for bacterial systems: Current achievements and future directions.
    Choi KR; Lee SY
    Biotechnol Adv; 2016 Nov; 34(7):1180-1209. PubMed ID: 27566508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Easy efficient HDR-based targeted knock-in in
    Singh R; Chandel S; Ghosh A; Gautam A; Huson DH; Ravichandiran V; Ghosh D
    Bioengineered; 2022 Jun; 13(6):14857-14871. PubMed ID: 36602175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type II Anti-CRISPR Proteins.
    Hwang S; Maxwell KL
    J Mol Biol; 2023 Apr; 435(7):168041. PubMed ID: 36893938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing Metabolic Engineering of Saccharomyces cerevisiae Using the CRISPR/Cas System.
    Lian J; HamediRad M; Zhao H
    Biotechnol J; 2018 Sep; 13(9):e1700601. PubMed ID: 29436783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.
    Tarasava K; Oh EJ; Eckert CA; Gill RT
    Biotechnol J; 2018 Sep; 13(9):e1700586. PubMed ID: 29917318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome editing systems across yeast species.
    Yang Z; Blenner M
    Curr Opin Biotechnol; 2020 Dec; 66():255-266. PubMed ID: 33011454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CRISPR/Cas-based genome editing in Aspergillus niger].
    Zheng X; Zheng P; Sun J
    Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):980-990. PubMed ID: 33783162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A highly efficient single-step, markerless strategy for multi-copy chromosomal integration of large biochemical pathways in Saccharomyces cerevisiae.
    Shi S; Liang Y; Zhang MM; Ang EL; Zhao H
    Metab Eng; 2016 Jan; 33():19-27. PubMed ID: 26546089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.